Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Profit After Tax (2020 - 2025)

Treace Medical Concepts' Profit After Tax history spans 6 years, with the latest figure at -$9.4 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 1775.05% year-over-year to -$9.4 million; the TTM value through Dec 2025 reached -$59.0 million, down 5.85%, while the annual FY2025 figure was -$59.0 million, 5.85% down from the prior year.
  • Profit After Tax reached -$9.4 million in Q4 2025 per TMCI's latest filing, up from -$16.3 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$501000.0 in Q4 2024 to a low of -$21.2 million in Q2 2024.
  • Average Profit After Tax over 5 years is -$11.4 million, with a median of -$12.2 million recorded in 2022.
  • Peak YoY movement for Profit After Tax: soared 92.02% in 2024, then tumbled 1775.05% in 2025.
  • A 5-year view of Profit After Tax shows it stood at -$6.6 million in 2021, then skyrocketed by 33.34% to -$4.4 million in 2022, then plummeted by 42.36% to -$6.3 million in 2023, then skyrocketed by 92.02% to -$501000.0 in 2024, then crashed by 1775.05% to -$9.4 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Profit After Tax are -$9.4 million (Q4 2025), -$16.3 million (Q3 2025), and -$17.4 million (Q2 2025).